Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLXT

Calyxt (CLXT) Stock Price, News & Analysis

Calyxt logo

About Calyxt Stock (NASDAQ:CLXT)

Advanced Chart

Key Stats

Today's Range
$6.01
$7.77
50-Day Range
$6.30
$31.50
52-Week Range
$1.25
$7.77
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Calyxt Completes One-for-Ten Reverse Stock Split
Calyxt Announces Effective Date of Reverse Stock Split
See More Headlines

CLXT Stock Analysis - Frequently Asked Questions

Calyxt, Inc. (NASDAQ:CLXT) issued its earnings results on Monday, May, 1st. The company reported ($5.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.00) by $2.45. The company earned $0.04 million during the quarter. Calyxt had a negative net margin of 9,979.64% and a negative trailing twelve-month return on equity of 259.69%.

Calyxt's stock reverse split on the morning of Thursday, June 1st 2023.The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Calyxt (CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/01/2023
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CLXT
CIK
1705843
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.89 million
Net Margins
-9,979.64%
Pretax Margin
-9,979.64%
Return on Equity
-259.69%
Return on Assets
-83.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.61
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$160 thousand
Price / Sales
195.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
11.67

Miscellaneous

Outstanding Shares
4,970,000
Free Float
4,865,000
Market Cap
$31.31 million
Optionable
Not Optionable
Beta
1.98

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:CLXT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners